Acadia Healthcare (NASDAQ:ACHC) Shares Up 5.8% on Strong Earnings

Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Get Free Report) traded up 5.8% during mid-day trading on Tuesday following a stronger than expected earnings report. The stock traded as high as $27.87 and last traded at $27.34. 385,181 shares were traded during trading, a decline of 83% from the average session volume of 2,228,106 shares. The stock had previously closed at $25.84.

The company reported $0.40 earnings per share for the quarter, beating the consensus estimate of $0.35 by $0.05. The firm had revenue of $770.51 million for the quarter, compared to the consensus estimate of $769.90 million. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. Acadia Healthcare's quarterly revenue was up .3% compared to the same quarter last year. During the same period last year, the firm posted $0.84 EPS.

Analysts Set New Price Targets

A number of research firms have commented on ACHC. KeyCorp dropped their price target on shares of Acadia Healthcare from $65.00 to $55.00 and set an "overweight" rating on the stock in a research report on Wednesday. Barclays dropped their price target on shares of Acadia Healthcare from $35.00 to $28.00 and set an "equal weight" rating on the stock in a research report on Wednesday. Guggenheim began coverage on shares of Acadia Healthcare in a research report on Wednesday, April 9th. They set a "buy" rating and a $36.00 price target on the stock. Royal Bank of Canada dropped their price target on shares of Acadia Healthcare from $64.00 to $43.00 and set an "outperform" rating on the stock in a research report on Monday, March 3rd. Finally, Bank of America dropped their price target on shares of Acadia Healthcare from $50.00 to $44.50 and set a "buy" rating on the stock in a research report on Friday, February 28th. One analyst has rated the stock with a sell rating, three have assigned a hold rating and six have issued a buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average target price of $47.94.

Institutional Trading of Acadia Healthcare

Hedge funds and other institutional investors have recently made changes to their positions in the business. Lindbrook Capital LLC raised its holdings in shares of Acadia Healthcare by 1,342.0% in the 4th quarter. Lindbrook Capital LLC now owns 721 shares of the company's stock worth $29,000 after purchasing an additional 671 shares in the last quarter. Blue Trust Inc. raised its holdings in shares of Acadia Healthcare by 69.4% in the 4th quarter. Blue Trust Inc. now owns 842 shares of the company's stock worth $33,000 after purchasing an additional 345 shares in the last quarter. Nisa Investment Advisors LLC raised its holdings in shares of Acadia Healthcare by 40.7% in the 4th quarter. Nisa Investment Advisors LLC now owns 1,040 shares of the company's stock worth $41,000 after purchasing an additional 301 shares in the last quarter. Signaturefd LLC raised its holdings in shares of Acadia Healthcare by 460.6% in the 4th quarter. Signaturefd LLC now owns 1,222 shares of the company's stock worth $48,000 after purchasing an additional 1,004 shares in the last quarter. Finally, Caitong International Asset Management Co. Ltd increased its position in shares of Acadia Healthcare by 11,218.2% in the first quarter. Caitong International Asset Management Co. Ltd now owns 1,245 shares of the company's stock worth $38,000 after acquiring an additional 1,234 shares in the last quarter.

Acadia Healthcare Stock Performance

The firm's 50-day moving average price is $26.19 and its two-hundred day moving average price is $35.54. The firm has a market capitalization of $2.41 billion, a PE ratio of 8.57, a P/E/G ratio of 1.46 and a beta of 1.01. The company has a quick ratio of 1.07, a current ratio of 1.07 and a debt-to-equity ratio of 0.60.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.